Patel Chintu 4/A
4/A · Amneal Pharmaceuticals, Inc. · Filed Mar 27, 2026
Research Summary
AI-generated summary of this filing
Amneal (AMRX) Co-CEO Chintu Patel Receives Performance RSU Award
What Happened Chintu Patel, Co-CEO and director of Amneal Pharmaceuticals (AMRX), was granted a performance-based restricted stock unit (RSU) award representing up to 544,663 shares on March 2, 2026. The award is a derivative compensation grant (reported at $0.00 per share) and the filing on March 27, 2026 is an amendment correcting the original March 3, 2026 Form 4 to clarify that 100% of the grant consists of performance-based RSUs.
Key Details
- Transaction date: March 2, 2026 (Period of Report). Amended Form 4 filed March 27, 2026; original Form 4 filed March 3, 2026.
- Transaction type/code: Award/Acquisition (A) — derivative grant of performance-based RSUs.
- Reported amount: 544,663 performance-based RSUs (reported as the maximum possible shares).
- Price: $0.00 (no cash paid by the insider for the award).
- Vesting/conditions: Units vest based on average closing price targets over a three-year performance period; payout may range from 0% to 200% of the target number. Any earned units vest in full on February 28, 2029.
- Shares owned after transaction: Not disclosed in this filing.
- Amendment note: This Form 4 corrects the Original Form 4, which had mistakenly reported non-performance RSUs; the entire grant is performance-based.
Context Performance-based RSUs are a form of compensation, contingent on meeting specified performance (stock-price) targets, and do not represent an immediate cash purchase or sale. Such grants are routine executive compensation and should not be interpreted alone as a direct bullish or bearish trading signal.
Insider Transaction Report
- Award
Performance-Based Restricted Stock Units
[F1][F2]2026-03-02+544,663→ 544,663 total→ Class A Common Stock (544,663 underlying)
Footnotes (2)
- [F1]Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F2]Represents a performance-based restricted stock unit grant of 544,663 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2029, the last day of the performance period.